https://www.marketscreener.com/quote/stock/MERTIVA-AB-64303538/news/Diamyd-Medical-AB-Limits-Further-Investment-in-the-Diabetes-Vaccine-39231252/?utm_source=telegram&utm_medium=social&utm_campaign=share